Saudi Pharmaceutical Industries (SPI)

Saudi Pharmaceutical Industries (SPI) is the first and only company in the Kingdom of Saudi Arabia that manufactures veterinary medicines. Established in 1994 in the central point of Third Industrial City, Riyadh, Saudi Arabia, SPI has obtained GMP quality standard and registration from the Ministry of Health. The company's modern factory is equipped with state-of-the-art machines, enabling it to meet local and international demand.

Under the leadership of Dr. Mohammed Ziadeh, SPI has rapidly expanded its presence, not only in Saudi Arabia but also across the GCC and several African countries. The company is known for manufacturing high-quality veterinary products that adhere to European standards and has also established itself as a reputable player in the local market, positioning itself as a strong competitor to multinational companies in the Gulf region and beyond.

As a Health Care, Manufacturing, and Pharmaceutical company, SPI contributes its products to some of the largest farms in the Kingdom, offering Mineral Blocks, Vitamin, and Mineral Premixes that are preferred by these farms. The company's commitment to quality and its ability to meet the evolving needs of the market make it an attractive proposition for potential investors and partners.

With its unique positioning as a pioneer in veterinary medicine production in Saudi Arabia and its ambitious expansion plans, SPI presents an interesting investment opportunity in the pharmaceutical industry. Investors seeking exposure to the growing healthcare sector in the region may find SPI an appealing prospect for potential collaboration and investment.